Implications of Pharmacogenomics for Anesthesia Providers


Pharmacogenomics considerations have the potential to develop therapeutic outcomes and individualise drug therapy while avoiding toxic effects and treatment failure by increasing the knowledge base of anaesthesia providers. However, because pharmacogenomics may not explain all inconsistencies in drug response, it must be used in conjunction with traditional anaesthesia considerations.

  • Drug Therapy
  • Drug Variability
  • Pharmacogenetics



 


    Related Conference of Implications of Pharmacogenomics for Anesthesia Providers

    October 19-20, 2026

    6th Euro-Global Summit on Probiotics & Nutraceuticals

    Paris, France
    November 16-17, 2026

    11th Global Summit on Midwifery and Womens Health

    Tokyo, Japan
    December 16-17, 2026

    7th Global Summit on Public Health

    Amsterdam, Netherlands
    January 18-19, 2027

    44th International Conference on Womens Health

    Bangkok, Thailand
    January 18-19, 2027

    10th World Congress on PCOS and Reproductive Healthcare

    Bangkok, Thailand
    February 01-02, 2027

    9th International Conference on Digital Health

    London, UK
    February 15-16, 2027

    23rd World Congress on Healthcare & Technologies

    Paris, France
    May 17-18, 2027

    38th European Heart and Heart Failure Congress

    Paris, France
    July 26-27, 2027

    5th Global Conference on Aging and Gerontology

    Paris, France
    August 24-25, 2027

    23rd Global Biomarkers and Clinical Research Summit

    Paris, France

    Implications of Pharmacogenomics for Anesthesia Providers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in